Efficacy of adjuvant capecitabine in triple-negative breast cancer with residual disease after neoadjuvant therapy: a real-world study.

Therefore, the breast-conserving rate of the capecitabine group was higher, but it did not reach statistical significance.

also in 111,027 other papers

With the addition of platinum-based drugs to the recommended NAT regimens for TNBC, the proportion of regimens combining anthracyclines with taxanes also demonstrated a decreasing trend.

also in 47,180 other papers